FR2590M - Nouvelles associations antinévralgiques a tolérance améliorée. - Google Patents

Nouvelles associations antinévralgiques a tolérance améliorée.

Info

Publication number
FR2590M
FR2590M FR927734A FR927734A FR2590M FR 2590 M FR2590 M FR 2590M FR 927734 A FR927734 A FR 927734A FR 927734 A FR927734 A FR 927734A FR 2590 M FR2590 M FR 2590M
Authority
FR
France
Prior art keywords
neuralgic
associations
new anti
improved tolerance
tolerance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR927734A
Other languages
English (en)
Inventor
Albert Beaufour
Gerard Beaufour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR927734A priority Critical patent/FR2590M/fr
Application granted granted Critical
Publication of FR2590M publication Critical patent/FR2590M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR927734A 1963-03-12 1963-03-12 Nouvelles associations antinévralgiques a tolérance améliorée. Expired FR2590M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR927734A FR2590M (fr) 1963-03-12 1963-03-12 Nouvelles associations antinévralgiques a tolérance améliorée.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR927734A FR2590M (fr) 1963-03-12 1963-03-12 Nouvelles associations antinévralgiques a tolérance améliorée.

Publications (1)

Publication Number Publication Date
FR2590M true FR2590M (fr) 1964-06-15

Family

ID=87430957

Family Applications (1)

Application Number Title Priority Date Filing Date
FR927734A Expired FR2590M (fr) 1963-03-12 1963-03-12 Nouvelles associations antinévralgiques a tolérance améliorée.

Country Status (1)

Country Link
FR (1) FR2590M (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004049095A2 (fr) * 2002-11-25 2004-06-10 Jallal Messadek Compositions de betaine
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
US7780990B2 (en) 2005-02-15 2010-08-24 Jallal Messadek Combination therapeutic compositions and method of use
US7786077B2 (en) 2005-04-27 2010-08-31 Jallal Messadek Insulins combinations
US8318805B2 (en) 2004-11-10 2012-11-27 Jallal Messadek Modulation of nitric oxide synthases by betaines
US8343947B2 (en) 2003-07-15 2013-01-01 Jallal Messadek Therapeutic treatment

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
WO2004049095A2 (fr) * 2002-11-25 2004-06-10 Jallal Messadek Compositions de betaine
WO2004049095A3 (fr) * 2002-11-25 2004-12-23 Jallal Messadek Compositions de betaine
US8343947B2 (en) 2003-07-15 2013-01-01 Jallal Messadek Therapeutic treatment
US8318805B2 (en) 2004-11-10 2012-11-27 Jallal Messadek Modulation of nitric oxide synthases by betaines
US7780990B2 (en) 2005-02-15 2010-08-24 Jallal Messadek Combination therapeutic compositions and method of use
US7786077B2 (en) 2005-04-27 2010-08-31 Jallal Messadek Insulins combinations

Similar Documents

Publication Publication Date Title
DK101572C (da) Byggesæt.
DK108810C (da) Rullegardin.
FR3846M (fr) Nouvelles 4-amino-pipéridines.
DK115947B (da) Vagitorium.
DK105902C (da) Metalbor.
FR2590M (fr) Nouvelles associations antinévralgiques a tolérance améliorée.
FR3288M (fr) Anti-cholinergique.
DK107717C (da) Pattegummi.
NL148116B (nl) Weeflis.
FR3817M (fr) Nouvel anthelmintique.
NL144390B (nl) Binnenmaatmicrometer.
FR3840M (fr) Chlorothioxanthenes substitués.
DK115762B (da) Brevordner.
DK117268B (da) Luftpudefartøj.
OA00038A (fr) Polyculteur attelé.
NL144671B (nl) Spindop.
FR3046M (fr) Nouvelles phényléthanolamines.
DK108699C (da) Fingerring.
DK113039B (da) Stald.
FR3325M (fr) Nouvelles 2-alcoyl-4-pyridine-aldéhyde-thiosemicarbazones.
BE642025A (fr) Nouvelles indolylalcoylguanidines.
FR2550M (fr) Médicament a action anorexogene a base de phénylhydroxyéthylamines.
NL154649B (nl) Opraapwagen.
FR3512M (fr) Médicaments a base de 1-beta-d-arabinofuranosylcytosine.
DE1917365U (de) Kehrwalze.